Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2026-06-11 @ 12:08 PM
Study NCT ID:
NCT01171820
Status:
COMPLETED
Last Update Posted:
2016-06-27
First Post:
2010-04-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)
Sponsor:
Abbott Medical Devices
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
05-369 Diabetic Sub-study
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None